Multimodal treatment of advanced renal cancer in 2017
Author:
Affiliation:
1. Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Publisher
Informa UK Limited
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17512433.2017.1386552
Reference98 articles.
1. Renal cancer
2. Obesity and renal cell cancer – a quantitative review
3. Renal cell carcinoma and occupational exposure to chemicals in Canada
4. Prospective Evaluation of Analgesic Use and Risk of Renal Cell Cancer
5. Chronic Hepatitis C Infection as a Risk Factor for Renal Cell Carcinoma
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bioinformatics analysis identifies GLUD1 as a prognostic indicator for clear cell renal cell carcinoma;European Journal of Medical Research;2024-01-20
2. Interleukin 17 and Its Involvement in Renal Cell Carcinoma;Journal of Clinical Medicine;2022-08-24
3. Late-Onset Metastatic Renal Cell Carcinoma to the Thyroid Gland: An Unusual Airway Emergency;American Journal of Case Reports;2022-01-12
4. Effect of Fibrinogen and Prealbumin Ratio on Postoperative Survival Rate after Radical Nephrectomy;Advances in Clinical Medicine;2022
5. Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21);Expert Review of Anticancer Therapy;2021-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3